USPTO serial 90592554
VERGE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JAGANNATHAN, SIDDHARTH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VERGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William E. Anderson
William E. Anderson CHRISTENSEN, FONDER, DARDI & HERBERT PLLC11322 86TH AVENUE NORTHMAPLE GROVE, MN 55369United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Catheters for use in an embolization therapy system, featuring hydrogel precursors and applicator; embolectomy catheters; catheters for use in embolization procedures; microcatheters for use in treating anomalies vasculature of the body; catheters for use in embolization therapy in interventional radiology and oncology; catheters for use in embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; catheters for use in delivery of embolic agents under fluoroscopic control; vascular embolization system microcatheter; catheters for use in delivery of embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis; embolization catheters; embolic catheter devices for treating anomalies vasculature of the body; arterial embolectomy catheters; catheters for use in interventional radiology, namely, interventional oncology and peripheral hemostasis; catheters for use in delivery of differentiated liquid embolics; catheters for use in vascular embolization procedures; catheters for use with syringes in the delivery of embolic agents under fluoroscopic control; catheters sold as part of an embolization therapy system, featuring hydrogel precursors and applicator; catheter kit for use in embolization procedures; catheters for delivery of differentiated liquid embolics in interventional radiology; medical apparatus and instruments for embolization; microcatheters used in treating anomalies vasculature of the body; medical device, namely, arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, delivery catheters for embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatus, namely, system for vascular embolization procedures primarily featuring delivery catheters and stiffening wires for vascular embolization procedures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 20, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 1, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 1, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 1, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 1, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 1, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 30, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 30, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 30, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 1, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2021 | NWAP | NEW APPLICATION ENTERED | — |